Arxis, Inc. is an American manufacturer of precision-engineered components for environments where reliability is critical. The company supplies electronic interconnect solutions and specialized mechanical parts that operate inside defense platforms, spacecraft, commercial aircraft, medical devices, and industrial equipment. Because its products serve industries with demanding specifications and long qualification cycles, Arxis occupies a niche where switching costs for customers tend to be high.
The company became publicly traded on the Nasdaq under the ticker ARXS following an IPO in April 2026. Since then, it has drawn attention from analysts and investors focused on the aerospace and defense (A&D) sector and on reshoring of critical manufacturing capacity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Arxis was assembled through the combination of several specialized manufacturers previously held under the umbrella of Arcline Investment Management, a private equity firm focused on industrial technology and defense businesses. These underlying operations — spanning engineered polymers, electrical components, interconnect solutions, and mechanical parts — were reorganized under Arxis, Inc., which is headquartered in Bloomfield, Connecticut.
The company reports its business across two segments:
Arxis's business model is built around designing and manufacturing components that must meet strict performance and certification standards. Once a component is qualified for use in a specific defense or aerospace program, it often remains in production for years, generating recurring, program-based revenue. This "qualify and stay" dynamic is a defining feature of the company's financial profile.
Its primary revenue sources come from long-term contracts and purchase orders tied to defense and space systems, commercial aerospace platforms, medical technology, semiconductor testing, analytical instruments, and industrial automation. The company emphasizes domestic manufacturing, which aligns with government and customer preferences for secure supply chains.
Several factors make ARXS a point of interest for investors:
Investors should weigh several considerations before evaluating ARXS:
In my own research on names like ARXS, I find Tickeron’s AI Screener particularly useful for quickly filtering through technical indicators, fundamentals, and industry patterns. It helps surface comparable ideas without spending hours on manual screening, which keeps my process efficient when evaluating specialized industrials.
Arxis (ARXS) is a specialized manufacturer of engineered electronic and mechanical components for mission-critical applications, with a strong footprint in aerospace and defense. Its combination of technical qualification barriers, program-based recurring demand, and a consolidating business model gives it a distinctive market position among industrial suppliers. At the same time, its reliance on defense budgets, program concentration, and an acquisition-driven strategy are important factors for investors to understand. For those following the aerospace, defense, and critical-components landscape, Arxis remains a notable name to watch.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for ARXS turned positive on November 11, 2026. Looking at past instances where ARXS's MACD turned positive, the stock continued to rise in 3 of 3 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on ARXS as a result. In 6 of 7 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
ARXS moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +8.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARXS advanced for three days, in 21 of 26 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARXS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
ARXS broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ARXS entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. ARXS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.812) is normal, around the industry mean (5.050). ARXS's P/E Ratio (648.018) is considerably higher than the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (11.614) is also within normal values, averaging (18.367).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense